[curtis3389]

It seems that the committee is an panel of outside advisors for the FDA.

The advisors advised that Aduhelm should not be approved because it only helps with a likely contributor to Alzheimer's, and it doesn't actually help with Alzheimer's.

The FDA ignored the panel and approved the drug anyways.

I wonder about the financial incentives and the corruption in the FDA. Every drug maker wants to be the first with an approved Alzheimer's drug; there's a ton of money to be made there.

[jhayward]

> helps with a likely contributor to Alzheimer's

There is no evidence, and plenty of failed trials, to indicate that Amyloid plaque is a cause of Alzheimers.